LONG-TERM FOLLOW-UP OF PATIENTS WITH TYPE 2 REFRACTORY CELIAC DISEASE TREATED WITH AMG 714, AN ANTI-INTERLEUKIN 15 MONOCLONAL ANTIBODY, AT GEORGES POMPIDOU HOSPITAL

Sherine Khater  1     Ludovic Lhermitte  2     Julie Bruneau  2     Thierry Molina  2     Boris Rosenbaum  1     Olivier Chatelanat  1     Chantal Brouzes  2     Vahid Asnafi  2     Amel Bensalah  2     David Sibon  2     Olivier Hermine  2     Christophe Cellier  3    
1 Hopital Europeen Georges Pompidou, Paris, France
2 Hôpital Necker, Paris, France
3 European Georges Pompidou Hospital Dept. of Gastroenterology, Paris, France

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing